← SynDRA
ANAGLIPTIN
SynDRA canonical compound SYN0028572 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | DPP4 | SLC22A8 |
| Mechanism of action | dipeptidyl peptidase inhibitor |
| Indication | diabetes mellitus |
| Disease area | endocrinology |
All known targets
- DPP4
- DPP8
- DPP9
- FAP
- SLC22A8
Mechanisms of action (all sources)
- DPP4 inhibitor
- dipeptidyl peptidase inhibitor
- DPP4 MODULATOR
Drug classes
- Dipeptidyl-Peptidase IV Inhibitors
- Enzyme Inhibitors
- Hypoglycemic Agents
- Protease Inhibitors
Cross-references
Synonyms
- anagliptin HCl
- beskoa
- anagliptin hydrochloride
- suiny
- Anagliptine
- Anagliptina
- SK-0403
- Suiny
- CWP-403
- UNII-K726J96838
- CHEMBL1929396
- (S)-N-(2-((2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)amino)-2-methylpropyl)-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
- K726J96838
- CHEMBL1929387
- N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
- Anagliptin [INN]
- N-[2-({2-[(2s)-2-Cyanopyrrolidin-1-Yl]-2-Oxoethyl}amino)-2-Methylpropyl]-2-Methylpyrazolo[1,5-A]pyrimidine-6-Carboxamide
- Anagliptin (JAN/INN)
- SCHEMBL905393
- sk-0403
- anagliptinum
- RefChem:558016
- DTXCID201527613
- MFCD19443729
- C19H25N7O2
- ANAGLIPTIN [MI]
- ANAGLIPTIN [JAN]
- ANAGLIPTIN [WHO-DD]
- orb1300040
- GTPL11582
- CHEBI:136043
- LDXYBEHACFJIEL-HNNXBMFYSA-N
- BDBM50359366
- s5909
- SK0403
- AKOS027325601
- CS-4510
- FA31542
Look up ANAGLIPTIN in the interactive SynDRA portal →